RG
Redmile Group Portfolio holdings
AUM
$940M
1-Year Return
75.78%
This Quarter Return
+12.85%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.44B
AUM Growth
-$133M
(-5.2%)
Cap. Flow
-$46.4M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
50.14%
Holding
73
New
3
Increased
9
Reduced
33
Closed
4
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$57.1M |
| 2 |
Prime Medicine
PRME
|
$41M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$37.8M |
| 4 |
Replimune Group
REPL
|
$32.3M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$23.6M |
Top Sells
| 1 |
argenx
ARGX
|
$49.8M |
| 2 |
Prothena Corp
PRTA
|
$31.9M |
| 3 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$29.4M |
| 4 |
The Beauty Health Co
SKIN
|
$24.9M |
| 5 |
LivaNova
LIVN
|
$23.9M |
Sector Composition
| 1 | Healthcare | 98.91% |
| 2 | Industrials | 0.92% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stoke Therapeutics
STOK
$1.06B
| $5.93M | 0.24% |
642,430
-193,400
| -23% | -$1.79M |
|
52
Nuvation Bio
NUVB
$1.13B
| $5.82M | 0.24% |
3,031,009
| – | – |
|
53
Cabaletta Bio
CABA
$139M
| $4.29M | 0.18% |
464,252
-232,125
| -33% | -$2.15M |
|
|
NVTA
54
DELISTED
Invitae Corporation
NVTA
| $4.24M | 0.17% |
2,280,403
| – | – |
|
|
SLGC
55
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $3.77M | 0.15% |
1,500,000
-370,839
| -20% | -$931K |
|
56
Alpha Teknova
TKNO
$223M
| $3.15M | 0.13% |
558,099
| – | – |
|
57
Stereotaxis
STXS
$248M
| $3.08M | 0.13% |
1,487,495
| – | – |
|
58
Grifois
GRFS
$6.72B
| $2.77M | 0.11% |
+325,600
| New | +$2.77M |
|
59
The Oncology Institute
TOI
$307M
| $2.61M | 0.11% |
1,583,158
| – | – |
|
|
HOOK
60
DELISTED
HOOKIPA Pharma
HOOK
| $2.52M | 0.1% |
311,477
-144,748
| -32% | -$1.17M |
|
61
Invivyd
IVVD
$203M
| $2.16M | 0.09% |
1,440,725
-480,235
| -25% | -$720K |
|
|
ACHL
62
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $1.45M | 0.06% |
1,608,089
| – | – |
|
|
SONX
63
DELISTED
Sonendo, Inc.
SONX
| $1.41M | 0.06% |
498,131
| – | – |
|
64
Bioventus
BVS
$473M
| $1.4M | 0.06% |
535,950
-763,189
| -59% | -$1.99M |
|
65
Xeris Biopharma Holdings
XERS
$1.26B
| $1.39M | 0.06% |
1,046,587
| – | – |
|
66
Neurogene
NGNE
$279M
| $942K | 0.04% |
92,528
-79,319
| -46% | -$807K |
|
|
TCRR
67
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $731K | 0.03% |
731,379
-363,266
| -33% | -$363K |
|
68
Cytosorbents Corp
CTSO
$60.5M
| $413K | 0.02% |
266,365
| – | – |
|
|
BCEL
69
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $354K | 0.01% |
442,653
-357,653
| -45% | -$286K |
|
70
Humana
HUM
$37.4B
| – | – |
-16,961
| Closed | -$8.23M |
|
|
CUTR
71
DELISTED
Cutera, Inc.
CUTR
| – | – |
-194,573
| Closed | -$8.87M |
|
|
72
Prothena Corp
PRTA
$442M
| – | – |
-525,575
| Closed | -$31.9M |
|
|
73
The Beauty Health Co
SKIN
$251M
| – | – |
-2,109,564
| Closed | -$24.9M |
|